Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia A and B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06312475
What this trial is testing

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Suzhou Alphamab Co., Ltd. 53
Not applicableWithdrawnNCT01541527
What this trial is testing

Non Neutralizing Antibodies: Prevalence and Characterization

Who this might be right for
Hemophilia A
University Hospital, Montpellier
Post-approval studies (Phase 4)Study completedNCT00092976
What this trial is testing

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 15
Early research (Phase 1)Study completedNCT02270918
What this trial is testing

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

Who this might be right for
Thrombosis
Thomas Jefferson University 12
Not applicableStudy completedNCT03655340
What this trial is testing

Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

Who this might be right for
Haemophilia B
Swedish Orphan Biovitrum 91
Not applicableStudy completedNCT02300519
What this trial is testing

Thrombin Generation Numerical Models Validation in Haemophilic Case

Who this might be right for
Haemophilia BHaemophilia A
Centre Hospitalier Universitaire de Saint Etienne 40
Large-scale testing (Phase 3)Study completedNCT00618098
What this trial is testing

Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures

Who this might be right for
Reversal of Anticoagulant Treatment
Octapharma 200
Not applicableStudy completedNCT01234545
What this trial is testing

Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 35
Large-scale testing (Phase 3)Looking for participantsNCT05568719
What this trial is testing

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Who this might be right for
Hemophilia AHemophilia B
Pfizer 173
Not applicableEnrolling By InvitationNCT06285071
What this trial is testing

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

Who this might be right for
Haemophilia AHaemophilia B
Novo Nordisk A/S 23
Large-scale testing (Phase 3)Study completedNCT01662531
What this trial is testing

A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 27
Not applicableUnknownNCT06565481
What this trial is testing

Measurement Properties in People with Hemophilia

Who this might be right for
Hemophilia aHemophilia BMusculoskeletal Complication+1 more
University of Zurich 50
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Not applicableUnknownNCT03615053
What this trial is testing

Personalized Medicine for Canadians With Hemophilia

Who this might be right for
Hemophilia AHemophilia B
McMaster University 600
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Study completedNCT02764489
What this trial is testing

FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)

Who this might be right for
Hemophilia A or B With Inhibitors
Baxalta now part of Shire 45
Large-scale testing (Phase 3)Study completedNCT01392547
What this trial is testing

Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 72
Large-scale testing (Phase 3)Active Not RecruitingNCT06569108
What this trial is testing

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Who this might be right for
Hemophilia A Without InhibitorHemophilia B Without Inhibitor
Suzhou Alphamab Co., Ltd. 125
Not applicableStudy completedNCT00212459
What this trial is testing

The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs

Who this might be right for
Hemophilia AHemophilia B
New York Presbyterian Hospital 14
Early research (Phase 1)UnknownNCT04768699
What this trial is testing

Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Next Page